CapForce IBD Breakout Opportunities ETF
BOUT
7 hedge funds and large institutions have $237K invested in CapForce IBD Breakout Opportunities ETF in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
5.36% less ownership
Funds ownership: 7.2% → 1.84% (-5.4%)
22% less funds holding
Funds holding: 9 → 7 (-2)
77% less capital invested
Capital invested by funds: $1.01M → $237K (-$773K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
+$64.2K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$21.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$851K |
| 2 |
AF
Advisornet Financial
Minnetonka,
Minnesota
|
-$3.66K |
BOUT Hedge Fund Activity: Q2 2023 in Review
7 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in CapForce IBD Breakout Opportunities ETF (BOUT) for Q2 2023, worth a combined $237K — down 77% from $1.01M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of BOUT and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 2 added.
The largest buyer was Osaic Holdings, adding an estimated $64.2K. The largest seller was Citadel Advisors, exiting entirely with an estimated $851K sold.
- 7 institutional investors held CapForce IBD Breakout Opportunities ETF (BOUT) as of Q2 2023, down from 9 in Q1 2023.
- Funds reported $237K of CapForce IBD Breakout Opportunities ETF stock for Q2 2023, down 77% quarter-over-quarter.
- 0 funds opened new CapForce IBD Breakout Opportunities ETF positions in Q2 2023 and 1 closed out, a net change of -1 holder.
- The largest CapForce IBD Breakout Opportunities ETF buyer in Q2 2023 was Osaic Holdings, an estimated $64.2K added.
- The largest CapForce IBD Breakout Opportunities ETF seller in Q2 2023 was Citadel Advisors, an estimated $851K sold.
Based on aggregated 13F filings for Q2 2023.